- Alternative therapy cardiology critical care Dermatology Endocrinology & Metabolism gastroenterology GI & liver harm HEENT Hematology hepatology HIV Hospital medicine ID immunology infection Nephrology Neurology Oncology ophthalmology Orthopaedics patient satisfaction pulmonary medicine renal Reproductive health Rheumatology Surgery Syncope Toxicology Urology vascular
Tag Archives: Oncology
The risk of fatal cancer for the maximally exposed Level I veteran is 1.4% (upper bound of 3.5%). Almost all of the DU-induced cancer risk is associated with the risk incurred for lung cancer. DU fragments are predicted to increase … Continue reading
VA Resident Report: What is the association between squamous cell carcinoma and acquired factor VIII?
Following surgery for the patient in this case study, the tumor nor the coagulation inhibitor has recurred after 6 months’ follow-up. While it is possible that the inhibitor may have remitted spontaneously or remained in remission because of the therapy … Continue reading
VA Resident Report: What is the etiology and therapy options for Postobstructive community-acquired pneumonia?
The Bottom Line: This study encourages more limited antibiotic use in patients with PO-CAP. Our experience has been that when patients fail to respond to a first course of antibiotics, physicians repeat sputum cultures, which now are contaminated with newly … Continue reading
The Bottom Line: New diagnostic criteria, a Revised International Staging System, and the approval of three drugs (four others pending approval) have greatly advanced the treatment, diagnosis, staging, risk-stratification and management of MM. These changes, as well as others detailed … Continue reading
Supportive measures are also crucial in the correct management of differentiation syndrome. In the PETHEMA protocols, furosemide is usually administered to treat signs or symptoms of fluid overload. Some cases with refractory acute renal failure and/or fluid overload may need … Continue reading
Multiple myeloma is a malignant plasma cell tumor, which ranks second in terms of prevalence among the hematologic malignancies. Diagnostic criteria includes occurrence of a monoclonal component detectable on serum and/or urine electrophoresis, light chain restricted bone marrow plasmacytosis, and … Continue reading
Review of peripheral t cell lymphomas; clinical staging for common types of non-Hodgkin’s lymphoma (NHL); staging of NHL
Longo, DL. Chapter 110. Malingnancies of Lymphoid Cells. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds. Harrison’s Principles of Internal Medicine. 18th ed. New York: McGraw-Hill; 2012. Peripheral T Cell Lymphoma The peripheral T … Continue reading